The abstract is read at the publisher; the summary is JClub's.
Galectin-3 (Gal3) is linked to plaque-associated microglial responses in postmortem Alzheimer’s disease brains, correlating with increased LAMP1+ dystrophic neurites and cored plaque association.
- Why it matters: The molecular bridge between microglial dysfunction and amyloid-β (Aβ) pathology in Alzheimer’s disease remains unclear, limiting targets to connect inflammation with plaque biology.
- What they did: In AD patient tissue, Gal3+ microglia associated with cored plaques and correlated with LAMP1+ dystrophic neurites; in APP mice, Gal3 deficiency reduced plaque burden and neuritic dystrophy and increased TREM2 coverage, while in vitro and cell-free assays showed Gal3 modulates Aβ uptake, lysosomal processing, fibril binding, and secondary nucleation.
- The result: Gal3 deficiency suppresses type I interferon and microglial neurodegenerative transcriptional signatures, and Gal3-modified fibrillar Aβ reduces N2a neuronal cell number, implying Gal3 shapes Aβ remodeling and lysosomal handling in plaque-linked microglia.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.